SCHEMBL7373306

SCHEMBL7373306

NC(C(=O)c1nnc(CCCCN[C@@H]2N=CCN2)s1)C(NC(=O)OCc1ccccc1)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLS O94925 6/20 0.39
SMN1; SMN2 Q16637 1/20 0.34
CA2 P00918 1/20 0.34
CA5A P35218 1/20 0.34
CA1 P00915 1/20 0.33
ITGB3 P05106 3/20 0.33
ITGAV P06756 3/20 0.33
ITGA2B P08514 2/20 0.33
HDAC6 Q9UBN7 2/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC9 Q9UKV0 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33
KLK8 O60259 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8177321 0.84 ITGB3 (0.42) GLSITGB3ITGAVITGA2B
SCHEMBL8177160 0.79 MAPT (0.38) GLSITGB3ITGAVITGA2B
SCHEMBL7368311 0.79 ANPEP (0.45) GLSSMN1; SMN2ITGB3ITGAVITGA2B
SCHEMBL7367243 0.78 SLC1A3 (0.47) ITGB3ITGAVITGA2BF2
SCHEMBL7366853 0.75 SLC1A3 (0.34) ITGB3ITGAVITGA2B
SCHEMBL8548718 0.72 ITGB3 (0.41) ITGB3ITGAVITGA2B
SCHEMBL7366550 0.70 SLC1A2 (0.41) GLS
SCHEMBL7402861 0.69 ITGB3 (0.67) ITGB3ITGAVITGA2B
SCHEMBL8551009 0.67 ITGB3 (0.45) ITGB3ITGAVITGA2B
SCHEMBL8168330 0.66 ITGAV (0.44) ITGB3ITGAVITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1049693-A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS $g(a) v?$g(b) 3? ANTAGONISTS Du Pont Pharmaceuticals Company (US) 2000-11-08 EP disclosed
WO-1999026945-A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS αvβ3 ANTAGONISTS DU PONT PHARMACEUTICALS COMPANY (US) 1999-06-03 WO disclosed